Preventing ischemic stroke in the older adult.

Geoffrey Ling, Shari M. Ling

Research output: Contribution to journalArticle

Abstract

Stroke is a deadly and disabling disease that preferentially afflicts older adults. It shares common risk factors with myocardial infarction (MI), such as hypertension, diabetes, and hyperlipidemia. Blood pressure control, cholesterol reduction with statins, and glucose control reduce the risk for both stroke and MI. Additionally, management of atrial fibrillation with warfarin reduces stroke risk. Beyond risk factor reduction, antiplatelet therapy is an effective option for lowering the likelihood of stroke in at-risk patients. Among antiplatelet agents, aspirin has been shown effective for secondary stroke prevention as well as primary and secondary MI prevention; clopidogrel for secondary stroke and MI prevention; and both ticlodipine and dipyridamole for secondary stroke prevention. Combining antiplatelet agents is rational. Carotid endarterectomy should be considered for stroke prevention in patients with ischemic symptoms; for patients with asymptomatic stenosis, potential benefit must be balanced against surgical risk.

Original languageEnglish (US)
JournalCleveland Clinic Journal of Medicine
Volume72 Suppl 3
StatePublished - Oct 2005
Externally publishedYes

Fingerprint

Stroke
Myocardial Infarction
clopidogrel
Platelet Aggregation Inhibitors
Secondary Prevention
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dipyridamole
Carotid Endarterectomy
Warfarin
Risk Reduction Behavior
Hyperlipidemias
Atrial Fibrillation
Aspirin
Pathologic Constriction
Cholesterol
Blood Pressure
Hypertension
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Preventing ischemic stroke in the older adult. / Ling, Geoffrey; Ling, Shari M.

In: Cleveland Clinic Journal of Medicine, Vol. 72 Suppl 3, 10.2005.

Research output: Contribution to journalArticle

Ling, Geoffrey ; Ling, Shari M. / Preventing ischemic stroke in the older adult. In: Cleveland Clinic Journal of Medicine. 2005 ; Vol. 72 Suppl 3.
@article{190f00d6169e4c6ea2beed6c1cddf303,
title = "Preventing ischemic stroke in the older adult.",
abstract = "Stroke is a deadly and disabling disease that preferentially afflicts older adults. It shares common risk factors with myocardial infarction (MI), such as hypertension, diabetes, and hyperlipidemia. Blood pressure control, cholesterol reduction with statins, and glucose control reduce the risk for both stroke and MI. Additionally, management of atrial fibrillation with warfarin reduces stroke risk. Beyond risk factor reduction, antiplatelet therapy is an effective option for lowering the likelihood of stroke in at-risk patients. Among antiplatelet agents, aspirin has been shown effective for secondary stroke prevention as well as primary and secondary MI prevention; clopidogrel for secondary stroke and MI prevention; and both ticlodipine and dipyridamole for secondary stroke prevention. Combining antiplatelet agents is rational. Carotid endarterectomy should be considered for stroke prevention in patients with ischemic symptoms; for patients with asymptomatic stenosis, potential benefit must be balanced against surgical risk.",
author = "Geoffrey Ling and Ling, {Shari M.}",
year = "2005",
month = "10",
language = "English (US)",
volume = "72 Suppl 3",
journal = "Cleveland Clinic Journal of Medicine",
issn = "0891-1150",
publisher = "Cleveland Clinic Educational Foundation",

}

TY - JOUR

T1 - Preventing ischemic stroke in the older adult.

AU - Ling, Geoffrey

AU - Ling, Shari M.

PY - 2005/10

Y1 - 2005/10

N2 - Stroke is a deadly and disabling disease that preferentially afflicts older adults. It shares common risk factors with myocardial infarction (MI), such as hypertension, diabetes, and hyperlipidemia. Blood pressure control, cholesterol reduction with statins, and glucose control reduce the risk for both stroke and MI. Additionally, management of atrial fibrillation with warfarin reduces stroke risk. Beyond risk factor reduction, antiplatelet therapy is an effective option for lowering the likelihood of stroke in at-risk patients. Among antiplatelet agents, aspirin has been shown effective for secondary stroke prevention as well as primary and secondary MI prevention; clopidogrel for secondary stroke and MI prevention; and both ticlodipine and dipyridamole for secondary stroke prevention. Combining antiplatelet agents is rational. Carotid endarterectomy should be considered for stroke prevention in patients with ischemic symptoms; for patients with asymptomatic stenosis, potential benefit must be balanced against surgical risk.

AB - Stroke is a deadly and disabling disease that preferentially afflicts older adults. It shares common risk factors with myocardial infarction (MI), such as hypertension, diabetes, and hyperlipidemia. Blood pressure control, cholesterol reduction with statins, and glucose control reduce the risk for both stroke and MI. Additionally, management of atrial fibrillation with warfarin reduces stroke risk. Beyond risk factor reduction, antiplatelet therapy is an effective option for lowering the likelihood of stroke in at-risk patients. Among antiplatelet agents, aspirin has been shown effective for secondary stroke prevention as well as primary and secondary MI prevention; clopidogrel for secondary stroke and MI prevention; and both ticlodipine and dipyridamole for secondary stroke prevention. Combining antiplatelet agents is rational. Carotid endarterectomy should be considered for stroke prevention in patients with ischemic symptoms; for patients with asymptomatic stenosis, potential benefit must be balanced against surgical risk.

UR - http://www.scopus.com/inward/record.url?scp=33644612022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644612022&partnerID=8YFLogxK

M3 - Article

C2 - 16265940

VL - 72 Suppl 3

JO - Cleveland Clinic Journal of Medicine

JF - Cleveland Clinic Journal of Medicine

SN - 0891-1150

ER -